FDA Releases Guidance on Ebola Blood Donor Eligibility and Management

Summary

The Food and Drug Administration (FDA) has released a guidance document providing recommendations for assessing blood donor eligibility, deferral, and product management in response to an Ebola outbreak. The guidance, finalized in December 2015, notifies blood establishments of the FDA's determination that Ebola virus is a transfusion-transmitted infection.